Diabetes management technology pioneer Beta Bionics has achieved another milestone, successfully amassing $100 million in its latest Series D equity funding round. The recent accomplishment surpasses ...

In 2024, medtech IPOs began to come back, thanks to the likes of heart valve company Anteris Technologies and neurotech ...

Beta Bionics, Inc. has announced that it will release its financial results for the second quarter of 2025 after the markets close on July 29, 2025. Following the release, company management will host ...

In the wake of earning FDA clearance for its insulin pump and automated dosing software—which connect to a Dexcom continuous glucose monitor to create what’s known as a hybrid closed-loop system for ...

Beta Bionics (BBNX), a maker of insulin delivery devices, has disclosed terms for an upsized $113M initial public offering.

Beta Bionics and Zealand Pharma initiate home-use trial of the iLet™ bionic pancreas with dasiglucagon for autonomous bihormonal treatment of Type 1 diabetes First home-use trial of the bihormonal ...

Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...

Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M initial public offering. Beta Bionics (BBNX) hopes to list its shares on Nasdaq under the symbol BBNX. Lead bookrunners ...

Orange County is about to see the first initial public offering of 2025. Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to ...

Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now set its financial goalposts, aiming to raise $114.4m from the initial public ...

IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its ...

Beta Bionics Inc., which makes ­a “bionic pancreas,” has secured $60 million in a Series E funding round led by new investor Wellington Management. The funding fuels Beta Bionics’ continued ...